These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 9006812

  • 21. Inhibition of the renin-angiotensin system abolishes the proatherogenic effect of uremia in apolipoprotein E-deficient mice.
    Bro S, Binder CJ, Witztum JL, Olgaard K, Nielsen LB.
    Arterioscler Thromb Vasc Biol; 2007 May; 27(5):1080-6. PubMed ID: 17347482
    [Abstract] [Full Text] [Related]

  • 22. Upregulation of LOX-1 expression in aorta of hypercholesterolemic rabbits: modulation by losartan.
    Chen H, Li D, Sawamura T, Inoue K, Mehta JL.
    Biochem Biophys Res Commun; 2000 Oct 05; 276(3):1100-4. PubMed ID: 11027596
    [Abstract] [Full Text] [Related]

  • 23. Antiatherogenic effect of angiotensin converting enzyme inhibitor (benazepril) and angiotensin II receptor antagonist (valsartan) in the cholesterol-fed rabbits.
    Li J, Hirose N, Kawamura M, Arai Y.
    Atherosclerosis; 1999 Apr 05; 143(2):315-26. PubMed ID: 10217360
    [Abstract] [Full Text] [Related]

  • 24. Mechanical stretch and angiotensin II differentially upregulate the renin-angiotensin system in cardiac myocytes In vitro.
    Malhotra R, Sadoshima J, Brosius FC, Izumo S.
    Circ Res; 1999 Jul 23; 85(2):137-46. PubMed ID: 10417395
    [Abstract] [Full Text] [Related]

  • 25. Antiatherosclerotic effect of alacepril, an angiotensin-converting enzyme inhibitor, in monkeys fed a high-cholesterol diet.
    Miyazaki M, Takai S.
    Hypertens Res; 1999 Mar 23; 22(1):49-54. PubMed ID: 10221351
    [Abstract] [Full Text] [Related]

  • 26. Inhibitory effects of fluvastatin, a new HMG-CoA reductase inhibitor, on the increase in vascular ACE activity in cholesterol-fed rabbits.
    Mitani H, Bandoh T, Ishikawa J, Kimura M, Totsuka T, Hayashi S.
    Br J Pharmacol; 1996 Nov 23; 119(6):1269-75. PubMed ID: 8937733
    [Abstract] [Full Text] [Related]

  • 27. Failure of nifedipine to reduce atherogenesis in cholesterol-fed rabbits.
    Overturf ML, Smith SA.
    Artery; 1986 Nov 23; 13(5):267-82. PubMed ID: 3527114
    [Abstract] [Full Text] [Related]

  • 28. Protection of the arterial internal elastic lamina by inhibition of the renin-angiotensin system in the rat.
    Huang W, Alhenc Gelas F, Osborne-Pellegrin MJ.
    Circ Res; 1998 May 04; 82(8):879-90. PubMed ID: 9576107
    [Abstract] [Full Text] [Related]

  • 29. Regulation of aortic wall structure by the renin-angiotensin system in Wistar rats.
    Unkelbach M, Auch-Schwelk W, Unkelbach E, Jautzke G, Fleck E.
    J Cardiovasc Pharmacol; 1998 Jan 04; 31(1):31-8. PubMed ID: 9456274
    [Abstract] [Full Text] [Related]

  • 30. Endogenous angiotensin II and baroreceptor dysfunction: a comparative study of losartan and enalapril in man.
    Yee KM, Struthers AD.
    Br J Clin Pharmacol; 1998 Dec 04; 46(6):583-8. PubMed ID: 9862248
    [Abstract] [Full Text] [Related]

  • 31. Pharmacology of ACE inhibitors versus AT1 blockers.
    Vaughan D.
    Can J Cardiol; 2000 Aug 04; 16 Suppl E():36E-40E. PubMed ID: 10906625
    [Abstract] [Full Text] [Related]

  • 32. [The influence of angiotensin-converting enzyme inhibitors on collagen content of the aorta wall in experimental hypercholesterolemia].
    Wojakowski W, Gmiński J, Stajszczyk M, Goss M, Siemianowicz K, Machalski M.
    Przegl Lek; 1999 Aug 04; 56(11):716-9. PubMed ID: 10800584
    [Abstract] [Full Text] [Related]

  • 33. [Effects of Tongxinluo and Simvastatin on the stabilization of vulnerable atherosclerotic plaques of aorta in aortic atherosclerosis and molecular mechanism thereof: a comparative study with rabbits].
    Li Z, Yang YJ, Qin XW, Ruan YM, Chen X, Meng L, Zhang HD.
    Zhonghua Yi Xue Za Zhi; 2006 Nov 28; 86(44):3146-50. PubMed ID: 17313769
    [Abstract] [Full Text] [Related]

  • 34. Hypertension and atherosclerosis in cholesterol-fed rabbits. Part 1. Mild, two-kidney, one-clip Goldblatt hypertension treated with enalapril.
    Overturf M, Sybers H, Schaper J, Taegtmeyer H.
    Atherosclerosis; 1986 Mar 28; 59(3):283-99. PubMed ID: 3008772
    [Abstract] [Full Text] [Related]

  • 35. [Anti-atherosclerotic action of ACE inhibitors. I. Inactivation of the renin-angiotensin system].
    Stajszczyk M, Gmiński J.
    Postepy Hig Med Dosw; 1996 Mar 28; 50(2):157-71. PubMed ID: 8848424
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. The effect of renin-angiotensin axis inhibition on early atherogenesis in LDL-receptor-deficient mice.
    Sharabi Y, Grossman E, Sherer Y, Shaish A, Levkovitz H, Bitzur R, Harats D.
    Pathobiology; 2000 Mar 28; 68(6):270-4. PubMed ID: 11493760
    [Abstract] [Full Text] [Related]

  • 38. Angiotensin AT(1) receptor signalling modulates reparative angiogenesis induced by limb ischaemia.
    Emanueli C, Salis MB, Stacca T, Pinna A, Gaspa L, Madeddu P.
    Br J Pharmacol; 2002 Jan 28; 135(1):87-92. PubMed ID: 11786483
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [Protective effect of an angiotensin-converting-enzyme inhibitor on neurogenic pulmonary edema in rabbits].
    Chen Y, Song F, Lu G, Lu Z.
    Zhonghua Er Ke Za Zhi; 2014 Aug 28; 52(8):602-6. PubMed ID: 25224238
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.